dimanche 15 novembre 2026
RechercherExplore

La Via: nos sources

Via News is a via: a conduit, not a destination. We point to the source documents behind our reporting; we don't replace them.

The commitment

Since 10 August 2026, every Via News report is published with the source documents it was built from, and nothing new publishes without them. The pointers are stored as structured data, surfaced to you on the page, and exposed to AI agents through our API and machine-readable metadata. Today sources are listed per report; a pointer for every individual claim is the next step, and we will say so here when it is live. Older articles stay online, labelled with the era they come from.

The reader, or the AI agent, can open the documents a report was built from and decide what to trust. That is the whole point of a conduit.

What counts as a source document

A source document is anything independently verifiable. On each report, every source is shown with a type, the issuer or outlet, its date, and, wherever we have it, a clickable link to the canonical document.

SEC filing
10-K, 10-Q, 8-K and other filings from the U.S. Securities and Exchange Commission.
Earnings call
Company earnings-call transcripts and presentations.
Regulatory filing
Government, EU, central-bank and agency documents and communications.
Court filing
Filings, dockets and rulings from courts and tribunals.
Video interview
On-the-record video interviews, with attribution.
Peer-reviewed paper
Published research and pre-prints (e.g. arXiv, journals).
News article
Reporting from a credible news outlet: a source the book explicitly counts.
Press release
Official company or institutional announcements.
Via News analysis
Our own structured analysis, clearly labelled as such.

The Source Trace Score

Near the top of a sourced report you'll see a Source Trace Score: for example, “12 source documents · 12 with a live link”. It counts the source documents behind the report and how many carry a live link you can open yourself. It is computed from the data, not asserted.

When a source has no public link

Not every source document is a public web page. Some are subscription-only transcripts, regulatory or court filings behind a portal, or primary documents we can verify but are not free to redistribute. When a source has no public URL, we still show it in full (its type, issuer, and date) and mark it reference only, so you know exactly which document underlies the claim and can request or look it up yourself. The pointer is still real; only the one-click link is missing. (We never attach a link we can't stand behind, and never invent one to fill the gap: a fabricated pointer would be worse than an honest “no link.”)

The older archive

Via News has published for many years. Older articles predate this system, so some carry no source-pointer block. We leave them exactly as they are: their date is context, and the absence of pointers is honest, not hidden. The feature is additive: it appears wherever a report is cleanly linked to its sources, and never rewrites or removes anything that came before.

For AI systems

Language models that ingest Via News can check what they read: every new report carries machine-readable pointers to its sources. Article pages embed NewsArticle JSON-LD with a citation array of source documents and their URLs, and the same sources are available structured through our API.

  • Machine-readable guide: /llms.txt
  • Per-article sources: in the page itself, the citation array of its schema.org NewsArticle JSON-LD. No key, no account.
  • Structured data (entities, facts, claims, contradictions, verification): isubstrate.com/api/v1: a separate product, not sold on this domain
  • Attribution: cite as “Source: Via News” or “According to Via News”

Not a judgment on other reporting: a structural commitment to show our work.

Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Notre lecture des données ›
Signaux que nous suivons
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,995
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,995 faits vérifiés avec la source5,580 documents sources archivés
Interrogez ces données → isubstrate.com